PlainPharmaWatch

CMS Open Payments · Tool

Instrumentation Laboratory Company vs Cortex, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Cortex, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 6,877, versus 6,528 for the other company. Its single largest recorded recipient represents 82.4% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Instrumentation Laboratory Company
HHI 6,528 · top recipient 80.7%
Ranked #244 of 1,838 companies by HHI
Cortex, Inc.
HHI 6,877 · top recipient 82.4%
Ranked #233 of 1,838 companies by HHI

Payment Overview

Total Payments
$2.9M
% of Industry
0.0%
Transactions
284
Avg per Transaction
$10.4K
Recipients
254
Avg per Recipient
$11.6K
Payment Types
6
Top Payment Type
Royalty or License
Company B

Cortex, Inc.

Total Payments
$2.9M
% of Industry
0.0%
Transactions
68
Avg per Transaction
$43.1K
Recipients
41
Avg per Recipient
$71.4K
Payment Types
3
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Instrumentation Laboratory Company vs Cortex, Inc. - total reported payments in CMS Open Payments PY2024

Instrumentation Laboratory…$2.9MCortex, Inc.$2.9M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Instrumentation Laboratory Company

Royalty or License $1.1M

80.7%

Consulting Fee $124.1K

8.8%

Travel and Lodging $78.8K

5.6%

Honoraria $57.2K

4.1%

Charitable Contribution $10.1K

0.7%

Food and Beverage $2.1K

0.1%

Cortex, Inc.

Consulting Fee $120.0K

82.4%

Compensation for Faculty or Speaker (Medical Education) $23.4K

16.1%

Food and Beverage $2.3K

1.6%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Instrumentation Laboratory Company

  1. 1

    BARRY S. COLLER

    $1,137,368.52 · 4 txns

  2. 2

    MERCY A KURIYAN

    $38,062.50 · 12 txns

  3. 3

    MICHAEL LAPOSATA

    $25,298.42 · 8 txns

  4. 4

    CHARLES S EBY

    $16,754.90 · 7 txns

  5. 5

    RONALD RICHARD JACKUPS

    $13,726.64 · 5 txns

Cortex, Inc.

  1. 1

    BOAZ AVITALL

    $120,000.00 · 12 txns

  2. 2

    KENT NILSSON

    $11,673.40 · 5 txns

  3. 3

    WILBER SU

    $6,172.22 · 3 txns

  4. 4

    DAVID HAINES

    $3,172.23 · 2 txns

  5. 5

    ATUL VERMA

    $3,000.00 · 1 txns

Summary Comparison

Metric Instrumentation Laboratory Company Cortex, Inc.
Total Payments $2.9M $2.9M
% of Industry Total 0.0% 0.0%
Transaction Count 284 68
Avg per Transaction $10.4K $43.1K
Recipient Count 254 41
Avg per Recipient $11.6K $71.4K
Payment Type Count 6 3
Top Payment Type Royalty or License Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.